Melanoma (Etiology)
Scientists Find Clue to Skin Cancer Development
Published in Gene Therapy Weekly, November 9th, 1998
Herlyn's most recent studies focus on the "switch" that turns benign lesions into malignancies. Herlyn said, "This change determines the outcome of disease. By identifying the genes that turn the switch on, we can design new therapies to keep it turned off."
Thus far, two genes, Alphav and Beta3, which are found in the vitronectin receptor (a cell surface glycoprotein that promotes the spread of cells and often is found at sites of skin...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1998-11-09)
More Articles from Gene Therapy Weekly
- Gaucher's Disease
Stem Cell Gene Therapy Uses Methotrexate Selectable Retroviral Vector - Cancer Immunotherapy
GM-CSF and CD80 Gene-Transduction Cooperate in Antitumor Immunity - Cytokine Gene Transfer
Targeting Circulating IL-5 May Be Therapeutic for Asthmatics - Immunopathology
Anti-TNF(alpha) Products Have Therapeutic Merit in the Treatment of Crohn's Di - Suicide Gene Therapy
Cell-Specific Transgene Expression Prevents HSVtk/GCV Toxicity in the Liver - Vector Development
Chitosan-Based Vector/DNA Complexes May Be An Alternative Gene Delivery System - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
